Medical Equipment

New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment

* Lunit to showcase 7 poster presentations and 4 online publications, the company's largest publication set at ASCO to date * Findings demonstrate the practical effectiveness of Lunit's AI solutions in the pathological assessment of tumors across more than 16 primary cancer types SEOUL, South...

2022-05-27 08:30 2752

"To China, Empower Your Shared Future" the 2nd Round of CIIE Medtech Roadshow Open for Application Now

SHANGHAI, May 26, 2022 /PRNewswire/ -- "To China, Empower Your Shared Future" the 2nd CIIE Innovation Incubation Area - one of the most distinguished medtech trade show inChina has been officially launched since March, 2022. On the China International Import Expo (CIIE) platform, CIIE Innovation ...

2022-05-26 15:44 2843

SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit

First-of-its-Kind blood-based pan-cancer treatment response monitoring test SHENZHEN, China, May 25, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (ConformitéEuropéenne) Mark approval for SeekInClarityTM Cancer Treatm...

2022-05-25 20:30 2229

CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions

Companies announce signed letter of intent to collaborate on creating advanced products based on industry-leading Ingeo™ PLA and PHACT® PHA technologies to meet growing demand for sustainable materials across wide array of markets WOBURN, Mass. and PLYMOUTH, Minn., May 25, 2022 /PRNewswire/ -- CJ...

2022-05-25 07:00 3435

CONCEPT DESIGN MILESTONE FOR DHS SELF-SCREEN CHECKPOINT STATION ACHIEVED

Successful first stage design milestone for Micro-X Passenger Self screening station - Unlocks$0.7m second phase of work ADELAIDE, Australia and SEATTLE, May 24, 2022 /PRNewswire/ -- Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode x-ray technol...

2022-05-24 19:00 2308

OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

SAN JOSE, Calif., May 24, 2022 /PRNewswire/ -- OptraSCAN® , the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-...

2022-05-24 09:00 3910

SCAI & CBS Pulmonary Hypertension Masterclass 2022: Based on Global Perspectives Focusing on New Breakthroughs

SHANGHAI, May 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced that onMay 12, 2022, the "Pulmonary Hypertension Masterclass 2022" webinar was successfully held, co-organized by the National Center of Pulmonary Vascular Disease,Chi...

2022-05-24 08:30 2668

HistoSonics Announces Agreement with GE Healthcare

HistoSonics Breakthrough Liver Therapy System to Utilize GE's LOGIQ™ E10 for  Real-Time Imaging Guidance and Treatment Verification MINNEAPOLIS, May 23, 2022 /PRNewswire/ -- HistoSonics Inc., developer of a completely non-invasive platform using the science of histotripsy, today announced an agre...

2022-05-23 21:00 3425

Tulip Partners with Stanley Black & Decker on Global Operations Platform

* Platform to provide digital manufacturing solutions for Stanley Black & Decker operations * Jane Arnold, Vice President of Manufacturing Technology at Stanley Black & Decker, to join Tulip's Board of Directors BOSTON, May 21, 2022 /PRNewswire/ -- Tulip Interfaces ("Tulip") announced today t...

2022-05-21 03:53 10205

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

-- European Commission Decision Anticipated within Approximately 60 Days -- NEWTON, Mass. and FLORENCE, Italy, May 21, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini")...

2022-05-21 01:19 10670

Meihua International Medical Technologies Co., Ltd. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 20-F

YANGZHOU, China, May 20, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced that on May 18,...

2022-05-20 22:57 7630

All Border Ports in Guangxi Commenced Normal Operations

NANNING, China, May 19, 2022 /PRNewswire/ -- Statistics from the Department of Commerce of Guangxi Zhuang Autonomous Region show that during the May Day holiday in 2022, a total of 3,344 vehicles entered and exited throughGuangxi border highway ports, including 1,601 and 1,743 vehicles leaving an...

2022-05-19 21:39 2906

4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022

MINNEAPOLIS, May 19, 2022 /PRNewswire/ -- 4C Medical Technologies, Inc. ("4C Medical" or the "Company"), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, presented its global clinical experience from its initial A...

2022-05-19 20:06 2928

FSP, the Top Brand of Power Supply in Five Application Fields

-Edge Computing/Medical/Smart Energy/Gaming/PD Charger- TAIPEI, May 19, 2022 /PRNewswire/ -- FSP Group, the world's leading high-performance ODM & Modified STD power supply manufacturer, today unveils the next wave of products designed with bleeding-edge technology that outperforms their rivals....

2022-05-19 08:30 4447

New survey finds 87% of patients with long-term health conditions face stigma; nurses feel they lack time and resources to provide adequate support

* Research explores the "care gap" as well as physical, emotional and social challenges faced by those with long-term health conditions, such as living with a stoma or wound, managing diabetes, urinary retention, cancer and more * Global medical solutions and technology company Convatec is com...

2022-05-18 21:03 2874

HistoIndex Welcomes Life Sciences and MedTech Visionary, David John Jeans CBE, to Board of Directors

SINGAPORE, May 18, 2022 /PRNewswire/ -- HistoIndex , a global leading artificial intelligence digital pathology (AI-DP) provider, is very pleased to announce the appointment of Dr.David John Jeans CBE as Non-Executive Director of the company's Board. John brings with ...

2022-05-18 19:00 2578

The Kare Lab Launches Anti-Viral & Anti- Microbial Screen Protector

World-first and only silver and PET-based Anti-Virus (Coronavirus) film certified by ISO 21702, CE and FDA HONG KONG, May 18, 2022 /PRNewswire/ -- The Kare Lab, a leading supplier in providing medical-grade protective gears to leading institutes and hospitals globally, has launched a new Anti-Vi...

2022-05-18 13:26 4025

Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes

FAIRFIELD, N.J., 17 May, 2022  /PRNewswire/ -- Vela Diagnostics announced today the launch of its new PathoKey® MP UTI ID and AMR PCR Test for research use only (RUO*). This multiplex PCR-based test allows for the in vitro detection and differentiation of 14 pathogens that cause urinary tract in...

2022-05-17 22:00 2675

"VR Hands-On Training" -- Live-Action Clinical Training with Hand Tracking Selected as a Finalist for AWE Auggie Awards, the World's Biggest VR/AR Awards!

TOKYO, May 17, 2022 /PRNewswire/ -- Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji; hereafter "Jolly Good"), is pleased to announce that the latest version of "VR hands-on training", live-action clinical training with hand tracking which is a new function of medical VR, has ...

2022-05-17 21:00 2176

New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore

* Over the course of the VICTORIA study, there was a 4.2% reduction in annualized absolute risk with VERQUVO™ (vericiguat) compared with placebo in reducing the risk of cardiovascular death or heart failure (HF) hospitalization in adults with symptomatic chronic HF and ejection fraction less th...

2022-05-17 16:32 2127
1 ... 100101102103104105106 ... 145

Week's Top Stories